ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Small-Cell Lung Cancer in Columbus, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Non-Small-Cell Lung Cancer trials near Columbus, OH, USA:

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

Columbus, Ohio, United States and 43 other locations

type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Sunvozertinib

Phase 1, Phase 2

Dizal Pharma

Columbus, Ohio, United States and 123 other locations

This is a phase 3 study to evaluate zimberelimab (AB122) combined with domvanalimab (AB154) compared to pembrolizumab in front-line, PD-L1-high, loca...

Active, not recruiting
Squamous Non Small Cell Lung Cancer
Nonsquamous Non Small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Pemetrexed

Phase 3

Arcus Biosciences
Arcus Biosciences

Columbus, Ohio, United States and 167 other locations

This is an open-label, multicenter, non-randomized, Phase 2 study to determine the safety, tolerability and efficacy of encorafenib given in-...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: encorafenib
Drug: binimetinib

Phase 2

Pfizer
Pfizer

Columbus, Ohio, United States and 156 other locations

This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small ...

Active, not recruiting
Non-small Cell Lung Cancer (NSCLC)
Cancer
Drug: Cofetuzumab Pelidotin

Phase 1

AbbVie
AbbVie

Columbus, Ohio, United States and 25 other locations

pembrolizumab as maintenance therapy in patients with stage IV non-squamous non-small cell lung cancer...

Active, not recruiting
Stage IV Non-small Cell Lung Cancer
Drug: Pemetrexed
Drug: Pembrolizumab

Phase 1, Phase 2

University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center

Columbus, Ohio, United States and 2 other locations

An Open Label, Multi-Center, Dose Escalation/Expansion, Phase 1/1b Study of IMU 201 (PD1-Vaxx), a B-Cell Immunotherapy as monotherapy or in -...

Active, not recruiting
Large Cell Carcinoma Lung
Squamous Non-small-cell Lung Cancer
Biological: IMU-201 (administered as PD1-Vaxx) - Regimen 3
Biological: IMU-201 (administered as PD1-Vaxx) - Regimen 1

Phase 1

Imugene

Columbus, Ohio, United States and 5 other locations

Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated non-small cell lung cancer (NSCLC) t...

Enrolling
Non-small Cell Lung Cancer
Drug: SBRT
Drug: Alectinib

Phase 2

Genentech
Genentech

Columbus, Ohio, United States and 33 other locations

The purpose of eVOLVE-Lung02 is to test the effectiveness (efficacy) and measure the safety of volrustomig in combination with chemotherapy ...

Enrolling
Metastatic Non-small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Pemetrexed

Phase 3

AstraZeneca
AstraZeneca

Columbus, Ohio, United States and 233 other locations

in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...

Enrolling
Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer
Drug: platinum-based chemotherapy
Drug: furmonertinib 240 mg oral, daily

Phase 3

ArriVent BioPharma
ArriVent BioPharma

Columbus, Ohio, United States and 204 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems